Arkolith/Insider Trading/PHAT/Form 4

Topper James N

DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed May 13, 2025
Net Buying
Open-Market Buys
$153K
Open-Market Sells
$0
Net Open-Market Flow
$153K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2025Buy(P)13K$3.04$38K48K
May 9, 2025Buy(P)2K$3.62$8K36K
May 9, 2025Buy(P)33K$3.19$106K33K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-012770) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML